EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

182 hedge funds and large institutions have $567M invested in Eagle Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 53 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
-7
Holders Change %
-3.7%
% of All Funds
4.06%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
71
Reduced
53
Closed
34
Calls
$3.18M
Puts
$6.12M
Net Calls
-$2.94M
Net Calls Change
-$5.36M

Top Buyers

1
PWAM
Park West Asset Management
California
+$12.4M
2
Millennium Management
Millennium Management
New York
+$11M
3
WG
Winton Group
United Kingdom
+$9.55M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.31M
5
Marshall Wace
Marshall Wace
United Kingdom
+$4.49M

Top Sellers

1
IAM
Iridian Asset Management
Connecticut
-$64.9M
2
Victory Capital Management
Victory Capital Management
Texas
-$20.4M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$14.8M
4
GIP
Granite Investment Partners
California
-$14.4M
5
Citadel Advisors
Citadel Advisors
Florida
-$10.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Marshall Wace
26
Marshall Wace
United Kingdom
$4.49M +$4.49M +111,464 New
AL
27
AJO LP
Pennsylvania
$4.12M +$1.26M +31,373 +44%
AQR Capital Management
28
AQR Capital Management
Connecticut
$3.93M +$1.17M +29,091 +43%
DZ Bank
29
DZ Bank
Germany
$3.9M -$529K -13,499 -12%
Two Sigma Investments
30
Two Sigma Investments
New York
$3.76M +$3.76M +93,260 New
Morgan Stanley
31
Morgan Stanley
New York
$3.61M -$651K -16,166 -15%
Principal Financial Group
32
Principal Financial Group
Iowa
$3.6M -$27K -669 -0.7%
LSV Asset Management
33
LSV Asset Management
Illinois
$3.36M -$244K -6,052 -7%
UBS Group
34
UBS Group
Switzerland
$3.27M +$2.79M +69,367 +587%
Charles Schwab
35
Charles Schwab
California
$3.16M -$211K -5,237 -6%
Bank of America
36
Bank of America
North Carolina
$3.06M +$931K +23,121 +44%
PAM
37
Panagora Asset Management
Massachusetts
$2.69M +$307K +7,611 +13%
Ameriprise
38
Ameriprise
Minnesota
$2.53M -$40.5K -1,005 -2%
William Blair & Company
39
William Blair & Company
Illinois
$2.46M -$431K -10,705 -15%
JPMorgan Chase & Co
40
JPMorgan Chase & Co
New York
$2.38M -$178K -4,426 -7%
SI
41
Scout Investments
Missouri
$2.27M +$455K +11,289 +25%
CAM
42
ClariVest Asset Management
California
$2.17M +$563K +13,971 +35%
CTA
43
Carillon Tower Advisers
Florida
$2.14M +$431K +10,700 +25%
Skandinaviska Enskilda Banken (SEB)
44
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.11M +$310K +7,700 +17%
PP
45
PDT Partners
New York
$1.79M -$1.14M -28,289 -39%
QI
46
QS Investors
New York
$1.69M – – –
AllianceBernstein
47
AllianceBernstein
Tennessee
$1.66M -$107K -2,660 -6%
Citadel Advisors
48
Citadel Advisors
Florida
$1.6M -$10.4M -258,954 -87%
Squarepoint
49
Squarepoint
New York
$1.54M +$1.54M +38,188 New
Connor, Clark & Lunn Investment Management (CC&L)
50
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.5M -$125K -3,100 -8%
1
2
3 4 5